Backtest tells the story here. Blue tells the returns.
Learning Fib. levels (entry levels): Fib. proposed this entry (4.55) on 29.04.18, I woulda proposed 3.70
Lil symmetrical triangle on the weekly. Looking for the breakout above $4.25 ($4.50-$4.75 to be safe). 50SMA crossover 200SMA would fit nicely for a confirmed breakout.
Looking for a buy opportunity in this. Right now I am not in it. In a down trend here.... lets see how low it goes. Support and Resistance at $4.23?
As we see, the price has been going up, falling back, going up, falling back, going up and now its time to fall back. Once we see how the price falls a little, we need to keep an eye on this one! I do think the price will go back to around 5-5.10 (we can see it always dropped to somewhere around the last high, just stood slightly above it) and then run up again....
this one right here will consolidate a bit before the next breakout. The EAM 200 says its a long position, the uptrend looks stabile, I think we will see a pullback to the support, or even the support below and thats my entry signal. If you look at it in the higher timeframes, you can see there was a trend reversal wit two big cups net to each other. Thats one...
AGEN is breaking through a lot os label of resistance. In longer therm its been declining from $10 & now getting some strength, and money flow is very strong now. It has huge insider buying from another Biotechnology company. We think it has very good upside potential. * Trade Criteria * Date First Found- July 17, 2017 Pattern/Why- Flag formation momentum...
Will be looking to enter under 3.60 NASDAQ:AGEN
This little fella popped up on my radar earlier today as having high implied volatility, so I pretty much blindly put on the covered call then and there, buying 100 shares a 6.24 and selling the Sept 16th 7 put for a 5.77 debit (which will be my cost basis in the shares). The max profit is $123 with a ROC of about 21.3% (assuming a call away at 7).
el precio debe mantenerse por encima de su EMA21 para continuar con potencial movimiento a la alza
Agenus Inc., an immuno-oncology company, focuses on the discovery and development of treatments that engage the bodys immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates using a high-throughput approach incorporating human antibody...
w/ a possible bull flag on 4hr time, watch for b/o of blue triangle
watch the 50% fib level if no vol, could be a false b/o. which would lead to a sell off